HilleVax, Inc.Employment Agreement • March 20th, 2024 • HilleVax, Inc. • Biological products, (no disgnostic substances) • New Jersey
Contract Type FiledMarch 20th, 2024 Company Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to offer you a position on the terms set forth in this letter (this “Agreement”), effective as of January 16, 2024.
HilleVax, Inc.Employment Agreement • March 20th, 2024 • HilleVax, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 20th, 2024 Company Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to continue to offer you a position on the terms set forth in this third amended and restated offer letter (this “Agreement”). This Agreement is entered into effective February 19, 2024 and amends and restates in its entirety the amended and restated offer letter between the Company and you that was dated January 6, 2023 (the “Prior Agreement”).
HILLEVAX, INC.Employment Agreement • March 17th, 2023 • HilleVax, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMarch 17th, 2023 Company Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to continue to offer you a position on the terms set forth in this amended and restated offer letter (this “Agreement”). This Agreement is entered into effective January 6, 2023 and amends and restates in its entirety the offer letter between the Company and you that was dated November 16, 2021 (the “Prior Agreement”).
HilleVax, Inc.Employment Agreement • March 17th, 2023 • HilleVax, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 17th, 2023 Company Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to continue to offer you a position on the terms set forth in this second amended and restated offer letter (this “Agreement”). This Agreement is entered into effective January 6, 2023 and amends and restates in its entirety the amended and restated offer letter between the Company and you that was dated March 1, 2021 (the “Prior Agreement”).
HilleVax, Inc.Employment Agreement • March 17th, 2023 • HilleVax, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 17th, 2023 Company Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to continue to offer you a position on the terms set forth in this second amended and restated offer letter (this “Agreement”). This Agreement is entered into effective January 6, 2023 and amends and restates in its entirety the amended and restated offer letter between the Company and you that was dated March 1, 2021 (the “Prior Agreement”).
HilleVax, Inc.Employment Agreement • March 17th, 2023 • HilleVax, Inc. • Biological products, (no disgnostic substances) • Washington
Contract Type FiledMarch 17th, 2023 Company Industry JurisdictionHilleVax, Inc. (the “Company”) is pleased to continue to offer you a position on the terms set forth in this amended and restated offer letter (this “Agreement”). This Agreement is entered into effective January 6, 2023 and amends and restates in its entirety the offer letter between the Company and you that was dated February 8, 2021 (the “Prior Agreement”).